Venturi Wealth Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Venturi Wealth Management’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-299	Closed	-$6.08K	–	1384
2023 Q3	$6.08K	Sell	299 -743	-71%	-$16.7K	﹤0.01%	922
2023 Q2	$24.3K	Sell	1,042 -1,096	-51%	-$26.3K	﹤0.01%	517
2023 Q1	$49.8K	Buy	+2,138	New	+$53.5K	﹤0.01%	469
2021 Q3	–	Sell	-3,874	Closed	-$202K	–	320
2021 Q2	$202K	Buy	+3,874	New	+$182K	0.02%	295

Other funds holding IDNA

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Venturi Wealth Management's IDNA Position: Q4 2023 in Review

Venturi Wealth Management sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q4 2023, closing a stake of 299 shares — an estimated $6.08K sold.

Venturi Wealth Management first reported a position in IDNA in Q2 2021 and held it in 4 quarters. The position peaked at $202K in Q2 2021. 66 funds tracked by Wall St. Rank hold IDNA as of Q4 2023.

Venturi Wealth Management reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q4 2023 after selling out during the quarter.
Venturi Wealth Management sold 299 iShares Genomics Immunology and Healthcare ETF shares in Q4 2023, an estimated $6.08K.
Venturi Wealth Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2021 and held it in 4 quarters.
Venturi Wealth Management's iShares Genomics Immunology and Healthcare ETF position peaked at $202K in Q2 2021.
66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q4 2023.

Based on Venturi Wealth Management's 13F filing for Q4 2023, filed 23 Jan 2024.